Prostate adenocarcinoma is a medical condition with active clinical research programs worldwide.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID	Title	Status	Phase
NCT04513717	Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial	ACTIVE_NOT_RECRUITING	PHASE3
NCT04134260	Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial	RECRUITING	PHASE3
NCT06312670	Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer	COMPLETED	PHASE2
NCT03274687	Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT06235151	Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer	RECRUITING	PHASE3
NCT06235099	Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer	COMPLETED	PHASE3
NCT05050084	Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial	RECRUITING	PHASE3
NCT04446117	Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC	ACTIVE_NOT_RECRUITING	PHASE3
NCT05027477	A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer	ACTIVE_NOT_RECRUITING	NA
NCT05946213	Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer	RECRUITING	PHASE3

Related Pages

All Prostate adenocarcinoma trials All trials in Cleveland, United States